19 December 2023 – London, UK, Munich, Germany: Generis and Userlane today announced a strategic partnership.
Generis is the developer of the CARA platform for data, content, and business process management in regulated industries, and Userlane is a Munich-based software adoption company for regulated industries. This collaboration aims to integrate their systems, helping customers of the CARA Platform to accelerate user adoption and rapidly achieve higher returns on investment.
The CARA Platform helps organizations streamline complex regulated business processes, data, and content on a single platform. It facilitates the instant creation, localization, and reuse of information, accelerating work and ensuring accuracy across organizational processes.
Userlane’s platform is designed to maximize the value of software investments. When working with the CARA Platform, it offers tailored process guides, on-demand support, and efficient onboarding and training processes. Userlane’s platform also allows enterprise customers to track and analyze software adoption within their organizations.
This partnership between Generis and Userlane lets companies use the best of both technologies. One platform supports business processes, ensuring compliance across various business areas, and supports efficient quality functions. As a result, it accelerates software implementation and adoption for Generis’ customers. Integrating Userlane into the CARA platform brings significant benefits, including:
- Quicker deployment and training on the CARA Platform
- Increased user satisfaction
- Improved customer communication
- Greater adoption of new features and updates on the CARA Platform
“This partnership addresses a crucial challenge many companies face: user adoption. Despite the widespread push toward technology adoption in regulated industries, adoption rates have varied. The integration with Userlane supports a smooth transition from complex systems to the comprehensive and feature-rich CARA Platform.”
James Kelleher, CEO at Generis
This collaboration marks a significant step towards accelerating software adoption in regulated industries, ensuring that companies can fully realize the value of their technology investments.
About Generis
Generis is a UK-headquartered developer of world-class data, content and business process management for regulated industries globally. 60% of the top 20 life sciences companies rely on Generis’ flagship CARA™ Life Sciences Platform, including AbbVie, UCB, Biogen, Reckitt, Bristol Myers Squibb, Bayer, Pfizer, and Merck KGaA. Today Generis serves more than 750,000 users worldwide, across use cases ranging from RIM, Regulatory / R&D and Safety use cases to Clinical, Non-clinical, Quality GxP, CMC, Pharmacovigilance, Medical Information / Medical Affairs applications and more. More at generiscorp.com.
